Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module
August 05, 2022 08:00 ET
|
Certara
PRINCETON, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release 5.2.0 of Pinnacle 21 Enterprise, the Company’s...
Certara宣布与行业领先的癌症中心合作推进CAR-T细胞疗法
July 29, 2022 06:22 ET
|
Certara USA, Inc.
新泽西州普林斯顿, July 29, 2022 (GLOBE NEWSWIRE) -- Certara, Inc.(纳斯达克股票代码：CERT)为全球生物模拟领域的领军企业，今日宣布与纪念斯隆-凯特琳癌症中心(Memorial Sloan-Kettering Cancer...
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
July 28, 2022 08:00 ET
|
Certara
PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a 2-year collaboration with Memorial Sloan Kettering Cancer Center...
Certara Appoints Rosemary Crane as New Independent Board Member
July 25, 2022 08:00 ET
|
Certara
PRINCETON, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Rosemary Crane to its Board of Directors,...
Certara Appoints Eran Broshy as New Independent Board Member
July 13, 2022 08:00 ET
|
Certara
PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective...
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
July 12, 2022 08:00 ET
|
Certara
PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of...
Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development
June 28, 2022 08:00 ET
|
Certara
PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Discovery Simulator, a new software designed for...
Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
June 21, 2022 08:00 ET
|
Certara
PRINCETON, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Certara Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of new versions of its Immunogenicity (IG),...
Certara Reports First Quarter 2022 Financial Results
May 05, 2022 16:15 ET
|
Certara
PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2022. ...
Certara to Participate in Upcoming Investor Conferences
May 03, 2022 16:30 ET
|
Certara
PRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...